15-Lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size)

Prostaglandins and Other Lipid Mediators

Volumn 82, Issue 1-4, 2007, Pages 135-146

  Tang, Dean G ^a   Bhatia, Bobby ^a   Tang, Shaohua ^a   Schneider Broussard, Robin ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

15 Lipoxygenase 2; Cell growth; Cell senescence; Differentiation; Prostate cancer; Prostate epithelial cells; Stem cells

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; 15 LIPOXYGENASE 2; AMINO ACID; ANDROGEN; DNA; KRUPPEL LIKE FACTOR 6; LIPOXYGENASE; MESSENGER RNA; MITOGENIC AGENT; MUTANT PROTEIN; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; TUMOR SUPPRESSOR PROTEIN; UVOMORULIN;

ALTERNATIVE RNA SPLICING; CARCINOGENESIS; CELL AGING; CELL DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; DEREGULATION; DNA METHYLATION; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HORMONAL REGULATION; HUMAN; HUMAN CELL CULTURE; METABOLITE; NONHUMAN; PROMOTER REGION; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; TRANSGENE; UPREGULATION;

ADULT; ALTERNATIVE SPLICING; ARACHIDONATE 15-LIPOXYGENASE; CADHERINS; CELL AGING; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL ENLARGEMENT; EPITHELIAL CELLS; GENE EXPRESSION; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEINS;

EID: 33845330927     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2006.05.022     Document Type: Review

References (24)

1. Brash A.R., Boeglin W.E., and Chang M.S. Proc Natl Acad Sci USA 94 (1997) 6148
2. Kilty I., Alison L., and Vickers P.J. Eur J Biochem 266 (1999) 83
3. Shappell S.B., Boeglin W.E., Olson S.J., Kasper S., and Brash A.R. Am J Pathol 155 (1999) 235
4. Shappell S.B., Manning S., Boeglin W.E., et al. Neoplasia 3 (2001) 287
5. Shappell S.B., Keeney D.S., Zhang J., Page R., Olson S.J., and Brash A.R. J Invest Dermatol 117 (2001) 36
6. Xu X.C., Shappell S.B., Liang Z., et al. Neoplasia 5 (2003) 121
7. Gonzalez A.L., Roberts R.L., Massion P.P., Olson S.J., Shyr Y., and Shappell S.B. Hum Pathol 35 (2004) 840
8. Tang DG, Patrawala L, Calhoun T, et al. Mol Carcinog, in press.
9. Tang S., Bhatia B., Maldonado C., et al. J Biol Chem 277 (2002) 16189
10. Bhatia B., Tang S., Yang P., et al. Oncogene 24 (2005) 3583
11. Bhatia B., Maldonado C.J., Tang S., et al. J Biol Chem 278 (2003) 25091
12. Tang S., Bhatia B., Zhou J.-J., et al. Oncogene 23 (2004) 6942
13. Rashid M.G., Sanda M.G., Vallorosi C.J., Rios-Doria J., Rubin M.A., and Day M.L. Cancer Res 61 (2001) 489
14. Rios-Doria J., Day K.C., Kuefer R., et al. J Biol Chem 278 (2003) 1372
15. Kuefer R., Hofer M.D., Gschwend J.E., et al. Clin Cancer Res 9 (2003) 6447
16. Li L.C., Zhao H., Nakajima K., et al. J Urol 166 (2001) 705
17. Kallakury B.V., Sheehan C.E., Winn-Deen E., et al. Cancer 92 (2001) 2786
18. Woodson K., Hayes R., Wideroff L., Villaruz L., and Tangrea J. Prostate 55 (2003) 199
19. Castro P., Giri D., Lamb D., and Ittman M. Prostate 55 (2003) 30
20. Choi J., Shendrik I., Peacocke M., et al. Urology 56 (2000) 160
21. Narla G., Heath K.E., Reeves H.L., et al. Science 294 (2001) 2563
22. Chen C., Hyytinen E.R., Sun X., et al. Am J Pathol 162 (2003) 1349
23. Narla G., Difeo A., Reeves H.L., et al. Cancer Res 65 (2005) 1213
24. Narla G., DiFeo A., Yao S., et al. Cancer Res 65 (2005) 5761